ArticleInternational journal of critical illness and injury science
Evaluation of efficacy of sugammadex for reversal of neuromuscular blockade in patients undergoing major upper abdominal surgery.
Article in International journal of critical illness and injury science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What's new in critical illness and injury science? Enhancing anesthetic recovery - Evaluating the role of sugammadex in major abdominal surgeries.International journal of critical illness and injury scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rapid and complete reversal of neuromuscular blockade (NMB) allows for the adequate return of respiration and motor function, thereby expediting recovery and preventing micro-aspirations postoperatively. Diaphragmatic ultrasonography (DUS) is an easy, noninvasive and reliable diagnostic tool to quantify and assess respiratory function and exclude any postoperative residual curarization (PORC). Sugammadex, a modified gamma cyclodextrin reverses NMB faster and more reliably from a deep or profound blockade. We aimed to evaluate the efficacy of Sugammadex for the reversal of NMB in patients undergoing major upper abdominal surgery and to determine the risk of PORC using DUS. Methods: The present prospective, observational study included patients aged 18-65 years undergoing major upper abdominal surgery. The participants of Group A received Sugammadex and Group B received Neostigmine-Glycopyrrolate as reversal agent. Time of extubation and diaphragmatic thickness was noted at base line, 10 min-30 min postextubation. The statistical analysis was done using SPSS (Statistical Package for the Social Sciences) Version 21.0. Results: The time required to extubate was significantly shorter in Group A as compared to Group B (81.96 ± 37.30 s vs. 204.20 ± 99.91 s, Conclusion: Sugammadex is more effective in achieving rapid reversal of NMB compared to neostigmine. The use of diaphragm ultrasonography provides valuable insights into respiratory function and the risk of PORC postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.